돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 605967생성일: 2026년 10월 25일

Diisopropylethylamine → (5-Bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-(1-isopropylpiperidin-4-yl)phenyl]amine

https://huagongshe.com/reaction/605967

반응식

참여 물질

역할이름HCID투입량
반응물DiisopropylethylamineHCID 81531—
반응물5,8-Dibromo-(1,2,4)triazolo(1,5-a)pyrazineHCID 49758022—
반응물4-(1-Isopropylpiperidin-4-yl)anilineHCID 57590071—
용매IsopropanolHCID 3776—
생성물(5-Bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-(1-isopropylpiperidin-4-yl)phenyl]amineHCID 57590100—

반응 단계

N,N-Diisopropylethylamine (200 μL, 1.2 mmol) is added to a mixture of 4-(1-isopropylpiperidin-4-yl)phenylamine (220 mg, 1.0 mmol) and 5,8-dibromo-[1,2,4]triazolo[1,5-a]pyrazine (280 mg, 1.0 mmol) in iPrOH (5 mL) and heated at reflux for 48 h. The mixture is cooled and the solvent evaporated under reduced pressure to afford an orange-brown solid. This is partitioned between DCM (50 mL) and water (20 mL) and the layers are separated. The organic phase is washed with citric acid (10% aq., 3×25 mL). The combined washings are extracted with DCM (25 mL) and then made basic by addition of NaHCO3 (s). The mixture is extracted with DCM (3×25 mL) and the combined extracts dried over MgSO4 and evaporated. The crude product was purified by chromatography on silica gel, eluting with 5%-10% MeOH in DCM to afford the desired compound, contaminated with the starting aniline. This was recrystallised from MeOH to afford the pure title compound (110 mg).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07915256B2
출처 데이터셋uspto-grants-2011_03
ORD IDord-54fc59c1e7734eaa913bb1ff1fa7bf79
출처 메모uspto-grants-2011_03